Cgamp Antibody

Direct Answer: What Is a cGAMP Antibody?

A cGAMP antibody is a specialized immunological reagent designed to selectively bind, detect, and quantify cyclic GMP-AMP (cGAMP)—a vital dinucleotide second messenger produced by cyclic GMP-AMP synthase (cGAS) upon detecting cytosolic double-stranded DNA. In laboratory research, these antibodies enable precise quantification of 2'3'-cGAMP and 3'3'-cGAMP isomers across competitive ELISAs, immunofluorescence microscopy, and immunoprecipitation assays.

Because small cyclic dinucleotides like cGAMP are inherently low in immunogenicity, antibody generation relies on hapten conjugation to carrier proteins such as keyhole limpet hemocyanin (KLH) or bovine serum albumin (BSA). High-affinity polyclonal and monoclonal cGAMP antibodies allow researchers to map intracellular cGAS activity without requiring radioisotope labeling or destructive mass spectrometry extraction procedures.

Biological Context: The cGAS-STING Signaling Axis

The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) pathway functions as a primary cytosolic DNA-sensing mechanism in mammalian innate immunity. Upon binding double-stranded DNA (dsDNA)—originating from viral pathogens, intracellular bacteria, or mitochondrial damage—cGAS catalyzes the synthesis of 2'3'-cGAMP from ATP and GTP.

The resulting endogenous second messenger, 2'3'-cGAMP, contains non-canonical 2'-5' and canonical 3'-5' phosphodiester linkages. This structural motif binds STING dimers anchored at the endoplasmic reticulum, triggering a conformational shift that leads to STING translocation to the Golgi apparatus. Subsequent recruitment of TANK-binding kinase 1 (TBK1) and IκB kinase (IKK) phosphorylates interferon regulatory factor 3 (IRF3) and NF-κB, inducing the expression of Type I interferons and pro-inflammatory cytokines.

Utilizing a highly specific cgamp antibody provides researchers with a direct assay handle to monitor endogenous cGAMP generation. Tracking these concentration changes in vitro provides clear insight into enzymatic cGAS activation kinetics and cellular stress responses.

Structural Isomers and Antibody Specificity Profiles

Cyclic dinucleotides exist in distinct structural configurations depending on their biological origin. Mammalian cells generate endogenous 2'3'-cGAMP containing a mixed 2'-5' and 3'-5' phosphodiester linkage, whereas bacterial species synthesize 3'3'-cGAMP featuring uniform 3'-5' linkages.

When evaluating immunoreagents, verifying cross-reactivity parameters is vital. Premium cGAMP antibodies demonstrate high nanomolar or sub-nanomolar affinity for 2'3'-cGAMP with minimal cross-reactivity toward linear nucleotides (ATP, GTP, GMP, AMP) or non-target cyclic dinucleotides such as c-di-GMP and c-di-AMP. Researchers examining host-pathogen interactions often leverage specific antibody clones to differentiate between eukaryotic cGAS activation and bacterial cyclic dinucleotide secretion.

For additional information on related innate immune modulators, explore our comprehensive research peptides library to evaluate complementary compounds utilized in signaling assays.

In Vitro Laboratory Applications and Assay Development

In vitro immunoassay development remains the predominant application for cGAMP antibodies. Competitive enzyme-linked immunosorbent assays (ELISAs) represent the benchmark method for quantifying intracellular and extracellular cGAMP levels in cell lysates and tissue culture media. In these assays, immobilized or primary cGAMP antibodies compete between sample-derived cGAMP and a labeled tracer molecule.

Beyond immunoassay quantification, immunofluorescence (IF) protocols employ monoclonal cGAMP antibodies to visualize localized accumulation of second messengers within specific subcellular compartments. High-content screening workflows rely on these staining patterns to assess nuclear envelope breakdown, micronuclei formation, and viral DNA sensing in real time.

In biochemical screening assays, researchers utilize cGAMP antibodies in combination with recombinant cGAS proteins to screen candidate small molecules for cGAS inhibition or activation. To review our full catalog of research-grade reagents for cellular assays, visit our complete index of all peptides.

Preclinical Literature and Immuno-Oncology Investigation

Preclinical studies indicate that cytosolic DNA sensing via the cGAS-STING axis plays a decisive role in anti-tumor immunity, cellular senescence, and autoimmune disorders. In tumor microenvironment models, intracellular transfer of 2'3'-cGAMP through gap junctions or specialized transporters (such as SLC19A1 and LRRC8A) alerts adjacent immune cells, stimulating dendritic cell maturation and CD8+ T-cell priming.

In vitro models of systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome frequently exhibit constitutive cGAS activation due to impaired clearance of self-DNA. Quantifying elevated cGAMP levels with high-specificity antibodies enables researchers to evaluate therapeutic drug candidates targeted at cGAS enzymatic inhibition.

Furthermore, comparative research examining direct STING activation often compares natural cyclic dinucleotides against synthetic peptide conjugates and non-nucleotide agonists. You can read more about structural target activation mechanisms in our article on STING pathway agonists.

Comparative Analysis: cGAMP Antibodies vs. Alternative Detection Methods

Historically, quantification of cyclic dinucleotides relied on Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). While LC-MS/MS offers absolute quantification, it demands complex sample extraction, costly instrumentation, and extensive instrument calibration.

Immunoassays utilizing a targeted cGAMP antibody offer a high-throughput, cost-effective alternative capable of processing hundreds of sample lysates simultaneously. Additionally, cell-based fluorescent biosensors based on modified STING domains allow live-cell imaging but may alter endogenous signaling dynamics or exhibit variable transfection efficiencies.

Below is a comparison of common research tools evaluated alongside cGAMP antibodies in innate immunity workflows:

1. Direct 2'3'-cGAMP Standards: Used as reference calibrators in competitive assays and direct STING binding experiments. 2. Synthetic STING Agonists: Non-nucleotide compounds used to bypass cGAS activation and directly stimulate downstream STING assembly; explore detailed parameters in our cGAS-STING pathway overview. 3. Recombinant Fluorophore-Conjugated Antibodies: Designed for automated cell imaging without secondary antibody incubation steps.

Reconstitution, Handling, and Assay Preparation Protocols

Proper handling of antibody reagents ensures baseline stability and reproducible experimental outcomes. Lyophilized cGAMP antibody preparations should be reconstituted using sterile, double-distilled water or phosphate-buffered saline (PBS, pH 7.4) to achieve the designated stock concentration (typically 0.5 to 1.0 mg/mL).

Upon initial reconstitution, vortexing should be avoided to prevent protein denaturation or aggregation. Gentle inversion followed by brief centrifugation is recommended. Working solutions for competitive ELISA typically range from 0.05 to 1.0 µg/mL depending on tracer affinity, whereas immunofluorescence protocols generally require concentrations between 1.0 and 5.0 µg/mL.

For researchers managing high-throughput screens or requiring large-scale batch uniformity, institutional ordering details are available through our wholesale lab account portal.

Storage, Stability, and Freeze-Thaw Mitigations

To preserve antigen-binding affinity and antibody integrity, reconstituted stock solutions should be divided into single-use aliquots and stored at -20°C or -80°C. Repeated freeze-thaw cycles must be rigorously avoided, as cryo-stress causes immunoglobulins to aggregate or lose binding capacity.

If short-term storage at 2°C to 8°C is necessary, adding a sterile preservative such as 0.02% sodium azide (NaN3) prevents microbial growth. However, sodium azide must be omitted or dialyzed out if the antibody is used in live-cell functional experiments or conjugated with horseradish peroxidase (HRP), as azide inhibits peroxidase enzymatic activity.

Quality Verification: Analytical Standards and Supplier Verification

Experimental reproducibility relies entirely on reagent purity, specificity, and lot-to-lot consistency. PX1 Research adheres to stringent quality control criteria across all supplied laboratory compounds and antibodies.

Every production lot undergoes rigorous analytical testing, including Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination and Electrospray Ionization Mass Spectrometry (ESI-MS) or SDS-PAGE analysis to verify molecular weight and heavy/light chain integrity. Furthermore, specialized reagents undergo Chromogenic LAL assay screening to confirm low endotoxin limits (<0.01 EU/µg), preventing false-positive immune activation in delicate cell culture assays.

All products are manufactured in GMP-compliant facilities within the USA and shipped with a lot-specific Certificate of Analysis (COA) issued by an ISO 17025 accredited laboratory. Discover additional technical protocols in our guide on immunology research reagents.